Michael Swartzburg's most recent trade in Iovance Biotherapeutics Inc was a trade of 45,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 4, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Iovance Biotherapeutics Inc | Michael Swartzburg | Vice President, Finance (PAO) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 45,000 | 45,000 | - | - | Stock Option (right to buy) |